Vanda Pharmaceuticals Inc. (VNDA): Price and Financial Metrics
Vanda Pharmaceuticals Inc. (VNDA)
Today's Latest Price: $15.04 USD
0.07 (-0.46%)
Updated Jan 21 3:00pm
Add VNDA to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
VNDA Stock Summary
- VNDA's current price/earnings ratio is 6.63, which is higher than only 7.01% of US stocks with positive earnings.
- VNDA's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of merely 12.44% of US stocks.
- In terms of twelve month growth in earnings before interest and taxes, Vanda Pharmaceuticals Inc is reporting a growth rate of 152.59%; that's higher than 92.54% of US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to Vanda Pharmaceuticals Inc are DIOD, ACIW, CRNT, DLB, and ONDK.
- VNDA's SEC filings can be seen here. And to visit Vanda Pharmaceuticals Inc's official web site, go to www.vandapharma.com.
VNDA Daily Price Range
VNDA 52-Week Price Range
VNDA Stock Price Chart More Charts
VNDA Price/Volume Stats
| Current price | $15.04 | 52-week high | $30.91 |
| Prev. close | $15.11 | 52-week low | $11.83 |
| Day low | $14.86 | Volume | 287,504 |
| Day high | $15.35 | Avg. volume | 507,328 |
| 50-day MA | $16.21 | Dividend yield | N/A |
| 200-day MA | $14.97 | Market Cap | 802.19M |
Vanda Pharmaceuticals Inc. (VNDA) Company Bio
Vanda Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders. The company was founded in 2002 and is based in Washington, the District of Columbia.
Top Stories View All
Best & Worst Performing Stock Industries for January 20, 2020
Best & Worst Performing Small Cap Stocks for January 20, 2020
Best & Worst Performing Mid Cap Stocks for January 20, 2020
Best & Worst Performing Large Cap Stocks for January 20, 2020
Best & Worst Performing Mega Cap Stocks for January 20, 2020
View All Top Stories
Loading social stream, please wait...